PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Among those let go were all 27 scientists in the nation’s only lab that performs advanced genetic testing needed for hepatitis outbreaks. HealthDay News — Key labs at the U.S. Centers for Disease ...

The Trump administration is weighing a plan to cut nearly a third of the federal health budget and eliminate dozens of programs.

White and Hispanic US veterans with a diagnosis of ultrashort Barrett esophagus had an increased risk of persistent Barrett esophagus.

More than 150 million Americans might lose no-cost access to preventive care services under a case being heard at the US Supreme Court.

Hormone diets have taken off on social media as the latest weight loss trend, but their scientific validity remains ...

A new pill designed by Eli Lilly to help with weight loss and blood sugar control is showing promise in early studies.

Acute pancreatitis and chronic pancreatitis were associated with shorter life spans and increased long-term mortality.

Several hundred units of counterfeit Ozempic (semaglutide 1mg injection) were seized by the Food and Drug Administration.

Among patients with mPDAC, racial and ethnic minority patients are less likely to achieve quality indicators associated with survival.

A 2-item food security instrument captures similar mortality risk information as instruments with more items among adults in the US.

The Risk Estimation of Tumor REcurrence After Transplant score accurately predicted hepatocellular carcinoma recurrence after liver transplantation.